Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Yende, Sachin ^a,b   D'Angelo, Gina ^c   Mayr, Florian ^a,b   Kellum, John A ^a,b   Weissfeld, Lisa ^a,b   Kaynar, A Murat ^a,b   Young, Tammy ^a,b   Irani, Kaikobad ^b   Angus, Derek C ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 9; D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART DEATH; HEMOSTASIS; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME VARIABLE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; VITAL SIGN; AGED; AREA UNDER THE CURVE; BLOOD; CARDIOVASCULAR DISEASE; DEMOGRAPHY; HOSPITALIZATION; PNEUMONIA; TIME;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DEMOGRAPHY; FEMALE; HEMOSTASIS; HOSPITALIZATION; HUMANS; MALE; MORTALITY; PATIENT DISCHARGE; PNEUMONIA; RISK FACTORS; TIME FACTORS;

EID: 80051525363     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022847     Document Type: Article

References (41)

1. Brancati FL, Chow JW, Wagener MM, Vacarello SJ, Yu VL, (1993) Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet 342: 30-33.
2. Hedlund JU, Ortqvist AB, Kalin ME, Granath F, (1993) Factors of importance for the long term prognosis after hospital treated pneumonia. Thorax 48: 785-789.
3. Kaplan V, Clermont G, Griffin MF, Kasal J, Watson RS, et al. (2003) Pneumonia: still the old man's friend? Arch Intern Med 163: 317-323.
4. Koivula I, Sten M, Makela PH, (1999) Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch Intern Med 159: 1550-1555.
5. Waterer GW, Kessler LA, Wunderink RG, (2004) Medium-term survival after hospitalization with community-acquired pneumonia. Am J Respir Crit Care Med 169: 910-914.
6. Yende S, Angus DC, Ali IS, Somes G, Newman AB, et al. (2007) Influence of comorbid conditions on long-term mortality after pneumonia in older people. J Am Geriatr Soc 55: 518-525.
7. Bordon J, Wiemken T, Peyrani P, Paz ML, Gnoni M, et al. (2010) Decrease in Long-term Survival for Hospitalized Patients With Community-Acquired Pneumonia. Chest 138: 279-283.
8. Hsu JL, Siroka AM, Smith MW, Holodniy M, Meduri GU, (2011) One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System. Int J Infect Dis 15: e382-e387.
9. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P, (2004) Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination. N Engl J Med 351: 2611-2618.
10. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H, (1998) Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 351: 1467-1471.
11. Clayton TC, Thompson M, Meade TW, (2008) Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J 29: 96-103.
12. Corrales-Medina VF, Madjid M, Musher DM, (2010) Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 10: 83-92.
13. Toschke AM, Heuschmann PU, Wood O, Wolfe CDA, (2008) Temporal relationship between influenza infections and subsequent first-ever stroke incidence. Age Ageing afn232.
14. Samama MM, (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160: 3415-3420.
15. Yende S, D'Angelo G, Kellum JA, Weissfeld L, Fine J, et al. (2008) Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis. Am J Respir Crit Care Med 177: 1242-1247.
16. Milbrandt EB, Reade MC, Lee M, Shook SL, Angus DC, et al. (2009) Prevalence and significance of coagulation abnormalities in community-acquired pneumonia. Mol Med 15: 438-445.
17. Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, et al. (2004) Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Crit Care 8: R82-R90.
18. Epstein SE, Zhu J, Najafi AH, Burnett MS, (2009) Insights Into the Role of Infection in Atherogenesis and in Plaque Rupture. Circulation 119: 3133-3141.
19. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, et al. (2007) Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 167: 1655-1663.
20. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, et al. (1997) A prediction rule to identify low-risk patients with community acquired pneumonia. N Engl J Med 336: 243-50.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR, (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
22. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, et al. (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100: 1619-1636.
23. Levy MM, Fink M, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256.
24. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, et al. (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-710.
25. Halm EA, Teirstein AS, (2002) Management of Community-Acquired Pneumonia. N Engl J Med 347: 2039-2045.
26. National Death Index. http://www.cdc.gov/nchs/ndi.htm.
27. Cowper DC, Kubal JD, Maynard C, Hynes DM, (2002) A Primer and Comparative Review of Major U.S. Mortality Databases. Ann Epidemiol 12: 462-468.
28. Sathiakumar NM, Delzell ES, Abdalla OM, (1998) Using the National Death Index to Obtain Underlying Cause of Death Codes. J Occup Environ Med 40: 808-813.
29. Doody MM, Hayes HM, Bilgrad R, (2001) Comparability of National Death Index Plus and Standard Procedures for Determining Causes of Death in Epidemiologic Studies. Ann Epidemiol 11: 46-50.
30. Kasal J, Jovanovic Z, Clermont G, Weissfeld LA, Kaplan V, et al. (2004) Comparison of Cox and Gray's survival models in severe sepsis. Crit Care Med 32: 700-707.
31. Putter H, Fiocco M, Geskus RB, (2007) Tutorial in biostatistics: competing risks and multi-state models. Stat Med 26: 2389-2430.
32. Serhan CN, Chiang N, Van Dyke TE, (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361.
33. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM Jr, et al. (2008) Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Engl J Med 359: 2195-2207.
34. Keller TT, van der Sluijs KF, de Kruif MD, Gerdes VEA, Meijers JCM, et al. (2006) Effects on Coagulation and Fibrinolysis Induced by Influenza in Mice With a Reduced Capacity to Generate Activated Protein C and a Deficiency in Plasminogen Activator Inhibitor Type 1. Circ Res 99: 1261-1269.
35. Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM, (2001) C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol 21: 603-610.
36. Keller TT, van Wissen M, Mairuhu AT, van Doornum GJ, Brandjes DP, (2007) Acute respiratory tract infections in elderly patients increase systemic levels of hemostatic proteins. J Thromb Haemost 5: 1567-1569.
37. Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade TW, (1994) Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet 19;343: 435-439.
38. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS, (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172.
39. Balkwill F, Mantovani A, (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
40. Kannel WB, (2005) Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 40: 1215-1220.
41. Kelly J, Rudd A, Lewis RR, Hunt BJ, (2002) Plasma D-Dimers in the Diagnosis of Venous Thromboembolism. Arch Intern Med 162: 747-756.